Feasibility of Peripheral Angioplasty in Type D TASCII Lesions

NCT01297387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2011-02-21

No results posted yet for this study

Summary

This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria.

About 300 patients will be treated with usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.

Conditions

Interventions

OTHER

PTA BPG procedure,

Surgery PTA or BPG Procedure, according usual local clinical practice

Sponsors & Collaborators

  • IRCCS Multimedica

    lead OTHER

Principal Investigators

  • Ezio Faglia, MD · Diabetic Foot Centre IRCCS MultiMedica

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Completion
2009-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01297387 on ClinicalTrials.gov